“The bill has been submitted to the State Duma,” RIA Novosti quoted him as saying.
The essence of the mechanism is that if a foreign company refuses to supply medicine, Russia itself can produce this drug by paying the patent holder.
Earlier, at a meeting with Prime Minister Dmitry Medvedev, Artemyev spoke of precedents when foreign corporations refused to supply vital drugs to Russia.
In late October, the head of government instructed to amend the procedure for determining the initial price of the contract for the purchase of medicines.